Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 27, 2026 01:00 ET | Source: F. Hoffmann-La Roche Ltd

[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity

A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without...
January 26, 2026 17:16 ET | Source: Bragar Eagel & Squire

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or...
January 26, 2026 13:01 ET | Source: Qlarant

Mr. Arnold Williams Selected as Qlarant Board Chair

Easton, MD, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The Board of Directors for Qlarant, Inc. have selected Mr. Arnold Williams, CPA as Board Chair. Mr. Williams began his Qlarant board experience when he...
January 26, 2026 09:30 ET | Source: Jelou

Jelou Raises $10M to Build AI Apps That Move Money on WhatsApp

After proving its platform in highly regulated banking environments across Latin America, Jelou is now bringing WhatsApp-based transactional AI to the US.
January 26, 2026 09:00 ET | Source: DonorsChoose

Panda Cares® Funds $2.3 Million in Classroom Resources for Public Schools in Panda Express® Neighborhoods

New York, New York, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Today, Panda Cares®, the philanthropic arm of Panda Express®, is donating a total of $2.3 million to U.S. public school classrooms through...
January 26, 2026 08:55 ET | Source: Arhaus, Inc.

Arhaus Debuts Its Spring 2026 Collection: A Bold Expression of Craft, Color, and Comfort

BOSTON HEIGHTS, Ohio, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), today announced the launch of its Spring 2026 Collection, now available at...
January 26, 2026 08:30 ET | Source: Traws Pharma, Inc.

Traws Pharma Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients; Announces Plans for Added Indication for Tivoxavir Marboxil as a Prophylactic Treatment for Seasonal Influenza

Ongoing clinical results with ratutrelvir confirm a differentiated profile versus PAXLOVID® with fewer adverse events, no viral rebounds to date and faster time to sustained symptom resolution;...
January 26, 2026 08:00 ET | Source: Century Aluminum Company

Century Aluminum Joins EGA Project to Build First U.S. Smelter in Almost 50 Years

DUBAI, United Arab Emirates and CHICAGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Emirates Global Aluminium (EGA) and Century Aluminum Company (NASDAQ: CENX) announced today that they have entered into a...
January 26, 2026 08:00 ET | Source: LB Pharmaceuticals Inc

LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development Program

Topline data expected in 1Q 2028 Phase 2 bipolar depression trial initiation follows positive Phase 2 results in acute schizophrenia NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals...
January 26, 2026 07:00 ET | Source: Marker Therapeutics

Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology

HOUSTON, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company with the worldwide exclusive license of Multi-Antigen Targeted T cells...